Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Understand the key aspects of points and cash back rewards. Equip yourself with knowledge to maximize your benefits.
28,655 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Governments are treating chipmaking as strategic. This article explains why intel's national security role matters fo...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
A rising retirement tactic is gaining traction among mid-career anesthesiologists: tapping 401(K) balances at 55 to c...
Emails released in SEC filings reveal a heated confrontation between UWM and Two Harbors as the CCM deal vote approac...
Austin Niemiec returns to lead Rocket Pro as executives depart, signaling a strengthened wholesale channel amid a vol...
A trio of forces is reshaping how families preserve wealth for heirs. Rising long-term care costs, tax-policy uncerta...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
A disciplined investment approach blends steady dividend payers with selective high-yield assets to produce durable i...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
A new Fed chair could reshape policy and markets. This guide explains chair kevin warsh plans, the potential economic...